Potassium-Competitive Acid Blocker: Novel Class of Anti- Acid Drug

Journal Title: Current Trends in Gastroenterology and Hepatology - Year 2019, Vol 2, Issue 2

Abstract

Over the past several decades, great progress has been made on understanding mechanisms of gastric acid secretion for developing new anti-acid drugs. Until now most commonly used anti-acid drugs are histamine-2 receptor antagonists and proton pump inhibitors (PPIs) for patients to control acid related disease. However, several clinical limitations of these drugs had been reported. Recently, a new generation of potassium-competitive acid blockers (P-CABs) were launched for clinical use. It has been shown that these new drugs are more convenient and powerful to treat gastric acid-related diseases. In this article, we briefly reviewed the clinical use of this new anti-acid drug P-CAB.

Authors and Affiliations

Jaeyong Han MD, Seung Hun Lee MD, Tong Wang MD

Keywords

Related Articles

The Role of Transabdominal Sonography in the Diagnostics of Choledocholithiasis: Compared to Endoscopic Retrograde Cholangiopancreatography

Common bile duct stone (CBDS) or choledocholithiasis (ChL) is one of the major pathologies that lead to serious complications, and accurate and early diagnosis is very important. ChL diagnostics is based on clinical, lab...

Utilization of Traditional Anticoagulation for Venous Thromboembolism in Patients with Liver Cirrhosis: Is It Safe?

Patients with liver cirrhosis are known to have increased risk bleeding particularly from gastrointestinal tract. However, recent literature has shown that patients with liver cirrhosis are also at increased risk of deve...

Reflections About the Gut, A Microbiologist’s Perspective

Without doubt, the original function of the human gut was to digest and absorb food. Its epithelial cells absorb food after it has been processed to smaller components by enzymatic digestion. Comparable epithelial proces...

The Burgeoning Role of the Gastrointestinal Microbiota

With the release of the landmark publication containing the information that there were more microorganisms in the gastrointestinal tract than any other cells [1] the scienti􀏐ic community began to look at the functional...

Assessment of the Depression‐level effectiveness of the Curse Words in Young Adults in Private Co-Educational Pharmaceutical Instituions in Pune University, India: A Preplanned, Causal‐Pathway‐Based Analysis

Depression and substance abuse is on the increase all over the world. The poor and the rich are also involved in this dangerous habit has impact not only on reproductive health but also has impact on family, society, inc...

Download PDF file
  • EP ID EP573132
  • DOI 10.32474/CTGH.2019.02.000131
  • Views 53
  • Downloads 0

How To Cite

Jaeyong Han MD, Seung Hun Lee MD, Tong Wang MD (2019). Potassium-Competitive Acid Blocker: Novel Class of Anti- Acid Drug. Current Trends in Gastroenterology and Hepatology, 2(2), 121-122. https://europub.co.uk/articles/-A-573132